Background: Yeasts provide attractive expression platforms in combining ease of genetic manipulation and fermentation of a microbial organism with the capability to secrete and to modify proteins according to a general eukaryotic scheme. However, early restriction to a single yeast platform can result in costly and time-consuming failures. It is therefore advisable to assess several selected systems in parallel for the capability to produce a particular protein in desired amounts and quality. A suitable vector must contain a targeting sequence, a promoter element and a selection marker that function in all selected organisms. These criteria are fulfilled by a wide-range integrative yeast expression vector (CoMed™) system based on A. adeninivorans-and H. polymorpha-derived elements that can be introduced in a modular way.
Background
The exploitation of recombinant DNA technology to engineer expression systems for heterologous protein production provided a major task during the last decades. Production procedures had to be developed that employ platforms which meet both the demand for efficient mass production and criteria of safety and authenticity of the produced compounds [1, 2] . In this respect, yeasts offer considerable advantages over alternative microbial and eukaryotic cellular systems in providing low-cost screening and production systems for authentically processed and modified compounds. These organisms furthermore meet safety prerequisites in that they do not harbour pyrogens, pathogens or viral inclusions.
The initial yeast system developed for heterologous gene expression was based on the baker's yeast Saccharomyces cerevisiae. This platform has been successfully applied to the production of various FDA-approved pharmaceuticals including insulin [3] and HBsAg [4] . However, when using this system, certain limitations and drawbacks are often encountered, since S. cerevisiae tends to hyperglycosylate recombinant proteins; N-linked carbohydrate chains are terminated by mannose attached to the chain via an α1,3 bond, which is considered to be allergenic. Other restrictions are the consequence of the limited variety of carbon sources that can be utilised by this species, which limits the fermentation design options. Sometimes, the preferential use of episomal vectors leads to instabilities of recombinant strains; as a result, batch inconsistencies of production runs can be of major concern [2] . Therefore, alternative yeast systems have been defined that can potentially overcome the described limitations of the traditional baker's yeast. Examples include the two methylotrophic yeast species Hansenula polymorpha [5, 6] and Pichia pastoris [5, 7] , the dimorphic organism Arxula adeninivorans [8, 9] and others. These organisms share the capability to utilize a broad range of carbon sources, two of them (H. polymorpha and A. adeninivorans) can assimilate nitrate and are thermotolerant species, with the latter exhibiting a temperature-dependent dimorphism with hyphae formed at elevated temperature and alterations in the extent of O glycosylation. For all systems, a range of host strains and relevant genetic elements are available.
In case of the two methylotrophic species, engineered strains have been developed that exhibit human-like Nglycosylation patterns [6, 7, 10, 11] . The genome of both species has been completely deciphered [6, 7, 12] , and for H. polymorpha a microarray chip is available [13] . In case of dimorphic A. adeninivorans species, data on chromosomes and on a partial characterization of the genomes are already available [9] . A more detailed description of some of the platforms can be found in [14] and in a recent book on production of recombinant proteins and various chapters therein [1, 2, 6, 7, 9, 15] .
Despite the superior characteristics of yeast hosts in various developments, there is clearly no single system that is optimal for production of all possible proteins. Predictions of a successful development for a given protein can only be made to a certain extent when restricting the initial strain engineering to a single species. The availability of a wide-range yeast vector system enables the assessment of several yeasts in parallel for their capability to produce a particular protein in desired amounts and quality [16] [17] [18] . Examples for the application of such vectors are provided in the following overview.
Results and discussion
Design and optimization of the CoMed™ vector system
Since vector systems of different yeast species are based on different basic vectors it is very difficult to exchange single cassettes between the yeast systems. To reduce this disadvantage the CoMed™ vector system was established containing the pCoMed™ basic vector for integration of ARS, selection markers, rDNA sequences and expression cassettes. For this purpose, the single modules are flanked by identical restriction sites and are integrated in the same location of the basic vector. In this system, various modules can be integrated. A selection of rDNA elements derived from the A. adeninivorans or H. polymorpha clusters has been assessed for suitability as targeting sequences. Particular elements of both clusters derived from an ETS-18S -5.8S segment were found to be optimal. Due to high conservation of the included coding regions targeting of all yeast species is feasible [19] . If for instance the combination of rDNA and the ALEU2 gene is chosen, a range of yeasts with this auxotrophy can be targeted. The same holds for the insertion of a dominant selection marker like the E.coli-derived hph gene conferring resistance to hygromycin B in all yeast species tested so far. The expression cassette is inserted in a final step as fragments derived from pre-constructed plasmids. A range of such cassette elements exists harbouring a promoter of choice, among others the A. adeninivorans-derived TEF1 promoter mentioned before, and a S. cerevisiae PHO5 terminator separated by a multiple cloning site. Again, this promoter was found to be functional in all yeast species tested so far [20, 21] . A selection of ARS sequences is available that will result in either episomal (S. cerevisiae) or chromosomally integrated plasmids (Hansenula polymorpha). However inclusion of such a sequence may reduce the range of addressible hosts.
By easy exchange of modules, such a vector can be converted into a plasmid that is optimal for an individual platform, for instance by inserting an expression cassette with a MOX promoter element that elicits efficient gene expression in methylotrophic yeasts only. The general design of the plasmid CoMed™ with a selection of components is provided in Fig. 1 and Tab. 1, additional elements and a range of available host strains based on different species can be found in [14] . Variants of this basic vector for the production of antibodies and derivatives thereof are under development. In yet another design, it is possible to linearize the plasmids in a way that leaves behind all bacterial DNA sequences.
Wide-range application of the CoMed™ vector system
In a first set of examples, we present the generation of recombinants based on a range of yeast species applying a single vector to transformation. In a first construct, a combination of elements was used that is suited to transform all yeast species tested so far, an rDNA-sequence for widerange targeting and the E.coli-derived hph gene as dominant selection marker.
For proof of concept, an expression cassette was designed harbouring the Aequorea victoria-derived GFP gene inserted between the A. adeninivorans-derived TEF1 promoter and the PHO5 terminator of S. cerevisiae [18] . An arbitrary selection of yeast species was transformed by the vector linearized within the rDNA targeting sequence, namely S. cerevisiae, A. adeninivorans (budding cells and filamentous cells), H. polymorpha, Pichia pastoris, Debaryomyces polymorphus and D. hansenii. In all transformants, the heterologous DNA was observed to be mitotically stable integrated into the genome of the respective host. For GFP production, the transformants were cultured for 48 h in YEPD medium at 30°C and the produced GFP was detected by fluorescence microscopy. All transformants efficiently produced GFP as shown in Fig. 2 . The GFP was distributed within the cytosol and excluded from the vacuoles.
In a second construct, we combined an rDNA targeting sequence and an A. adeninivorans-derived LEU2 [20] for selection. For comparative production, the cytokine IL-6, a secreted protein of industrial relevance, was selected. Recombinant expression systems for IL-6 have been established among others based on E. coli [38] and S. cerevisiae [39] , in addition attempts have been described for H. polymorpha [40, 41] . In both systems, production is hampered by N-terminal truncation of the product, elicited by a thiol protease that cleaves the mature protein at Arg8 (Arg9 in E. coli) [42] . For assessment, we inserted an expression cassette harbouring an ORF for a MFα1/IL-6 fusion protein under control of the elements described before and transformed leu2 auxotrophic strains of A. adeninivorans, H. polymorpha and S. cerevisiae. Again, mitotically stable strains were generated. Representatives of the three derived strain collections efficiently secreted the recombinant cytokine into the medium. In this case, product differences could be observed when comparing the secretion products of the different yeast species: the H. polymorpha and S. cerevisiae-derived molecules were found to be of smaller size than that secreted from the A. adeninivorans host. A more detailed comparative MS analysis of tryptic peptides revealed an N-terminal truncation at position Arg8 in H. polymorpha and S. cerevisiae, but a correctly processed mature IL-6 in A. adeninivorans (Fig. 3) . This is probably due to the lack of a thiol protease in this dimorphic species. The result emphasizes the need of a careful early pre-selection of a platform for the development of a production process. A detailed description of comparative IL-6 production will be provided elsewhere.
Wide-range co-integration of different plasmids
It is possible to co-integrate multiple plasmids carrying expressible heterologous genes in the ribosomal DNA by a single transformation step [20, 43] . Again, using appropriate selection markers and a functional wide-range pro- 
Schw. occidentalis [24] rDNA region
A. adeninivorans [19] selection marker
P. pastoris [28] expression cassette (promoter) [37] moter for expression control, a comparative single-step integration in a range of selected yeast platforms becomes feasible. In the following section, three promising examples are described. 
Simultaneous introduction of a new metabolic pathway into different yeasts

Assessment of secretory pathway genes for the production of IFNγ
IFNγ is produced by CD4 and CD8-positive T and NK (natural killer) cells. The mature protein consists of 146 amino acids. IFNγ is a potent anti-viral and anti-parasitic agent. It has been assessed for treatment of opportunistic infections in AIDS patients, for treatment of eosinophilia in severe atopic dermatitis and for treatment of osteopetrosis [46, 47] . Two active forms of 25 and 20 kDa exist, differing in the extent of glycosylation. Glycosylation is not 
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Transformation procedure based on simultaneous integration of the plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC into the 25S rDNA of A. adeninivorans G1211 (aleu2) Figure 4 Transformation procedure based on simultaneous integration of the plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC into the 25S rDNA of A. adeninivorans G1211 (aleu2). The two plasmids pAL-HPH-phbA-phbB and pAL-ALEU2m-phbC containing the expression cassettes with phbA, phbB and phbC genes are linearised by BglII or Esp3I digestion, respectively. The resulting fragments flanked by 25S rDNA sequences are co-integrated into the 25S rDNA by homologous recombination. Transformants are selected either by resistance to hygromycin B (plasmid pAL-HPH-phbA-phbB [25, 44] ) or the complementation of the aleu2 mutation (plasmid pAL-ALEU2m-phbC [20] ). 
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adeninivorans yeast estrogen sensor (A-YES).
A. adeninivorans G1211 transformed with the plasmids pAL-HPHhERα and pAL-ALEU2m-GAA(2xERE-107)-phyK (G1211/pAL-HPH-hERα -pAL-ALEU2m-GAA(2xERE-107)-phyK) was the bio component of the A-YES. It expresses the estrogen receptor gene (TEF1 promoter -hERα gene -PHO5-terminator) constitutively and produces a relatively constant level of recombinant hERα independent of the estrogen concentration. In the presence of estrogen or estrogen analogues, however, hERα forms a hERα-estrogen-dimer complex, which binds to the EREregion of the GAA promoter located in the second reporter gene expression cassette. The cassette (GAA-ERE-promoter -phyK gene -PHO5 terminator) is activated, the phyK gene is expressed and phytase is synthesized. Since this enzyme contains a native signal sequence it is secreted and accumulates extracellularly. The recombinant phytase level is then quantified using a simple biochemical method.(C) Specificity of the A-YES based on A. adeninivorans G1211/pAL-HPH-hERα -pAL-ALEU2m-GAA(2xERE-107)-phyK for a range of steroids and steroid metabolites. The graphs depict the log concentration of 17α-ethynylestradiol (ᮀ), 17β-estradiol (■), estrone (▲), estriol (•), coumestrol (❍) and bisphenol A (+) plotted against the recombinant phytase activity of the medium after 30 h incubation. A B required for biological activity [48] but for proteolytic stability [49] . It is therefore desirable to have access to an efficient expression platform in which a cytokine can be produced as glycosylated protein. The protein has been produced in E. coli [50, 51] and in mammalian cells [52] .
IFNγ is poorly secreted from recombinant H. polymorpha cells in the form of hyperglycosylated molecules. In other examples, overexpression of secretory pathway genes has been shown to improve both, the yield and the quality of a recombinant product in several yeast platforms. Examples include the overexpression of KAR2 [53] , PDI [54] , SSO1/2 [55] , CMK2 [56] and KEX2 [57] . However, it became apparent that the observed improvements were restricted to a specific recombinant product development in meeting the demands to overcome a particular limitation in the respective recombinant strains. When encountering such limitations like poor secretion, impaired processing or glycosylation, it seems advisable to assess several candidate genes of the secretion machinery or even combination thereof for an enhanced probability of success. A selection of four secretory pathway genes was assessed for possible impact on secretion improvements in this case. For assessment, wide-range rDNA integration vectors harbouring the H. polymorpha-derived KAR2, PDI, SSO2 or CNE1 genes [58] were co-integrated along with the IFNγ integration/expression vector. Overexpression of CNE1 resulted in an increased secretion of the cytokine predominantly consisting of molecules of distinct size. Deglycosylation with PNGaseF resulted in a M r reduction of the secreted IFNγ corresponding to the removal of two N-linked glycoside chains. Coexpression of KAR2, PDI1 and SSO2 exhibited no effect (Fig. 6) . Again, co-integration into alternative yeasts is now feasible. Furthermore a co-integration of the IFNγ gene with more than a single secretory pathway gene can be envisaged.
Conclusion
The CoMed™ vector system is a versatile system built up in a modular way. Modules comprise of ARS sequences, rDNA targeting sequences and dominant or complementation selection markers. For expression cassettes, a choice of promoters from various sources is available, separated in the module by a MCS from an S. cerevisiae-derived PHO5 terminator.
A combination of an rDNA integration sequence and a suitable selection marker enables transformation of host Glycosylation analysis of secreted IFNγ Figure 6 Glycosylation analysis of secreted IFNγ. A strain of the pMrL-IFNg/pMrL-CNE collection was cultured on a 500 ml scale. The proteins of the supernatant were precipitated with (NH 4 ) 2 SO 4 . An aliquot of the precipitate was digested with PNGase F as described in Materials and methods. Untreated and PNGase F-treated protein samples were compared to isolates from a previous strain collection. The various samples were separated by SDS-PAGE; proteins were visualized by immunoblotting as described before. (1, 5, 9, 13) IFNγ standard (E.coli), (2, 6, 10, 14) H. polymorpha, (3, 4) H. polymorpha/CoMed8-MATα-IFNγ, (7, 8) A single type of plasmid or multiple types of plasmids can simultaneously be integrated into the genome of the various hosts.
The vector system thus provides a powerful tool to transform several yeasts in parallel at an early stage of a particular process development thereby avoiding potential costand time-consuming failures.
Materials and methods
Strains and media E. coli TOP 10 [F', mcrA, ∆(mrr-hsdRMS-mcrBC), Φ80 ∆lacZ-∆DM15, nupG, ∆lacX74, deoR, recA1, araD139, ∆(ara,leu), 7697, galU, galK, λ -, rpsL, endA1] from Invitrogen, USA, served as host strain for bacterial transformation and plasmid isolation. Strain was grown in LB medium supplemented with ampicillin (50 µg ml -1 ; AppliChem, Germany) when required for selection.
The yeast strains A. adeninivorans LS3 [59] , A. adeninivorans 135 [32] , A. adeninivorans G1211 ([aleu2 - [60] ), D. hansenii H158 (provided by the strain collection of UFZ, Leipzig/Germany), D. polymorphus H120 (provided by the strain collection of UFZ, Leipzig/Germany), P. pastoris GS115 (his4 -Invitrogen/USA) and the H. polymorpha MedHp1 (odc1 - [14] ) as well as S. cerevisiae C13ABYS86 (MATα leu2 ura3 his pra1 prb1 prc1 cps - [61] ) were used as hosts. All strains were grown either under non-selective conditions in complex medium (YEPD) or under selective conditions in a yeast minimal medium (YMM) supplemented with 2% of a selected carbon source [62, 63] . Cultivation was performed at 30°C. Agar plates were prepared by adding 1.6% (w/v) agar to the media. Hygromycin B (Roche Diagnostics, Germany) was added as 150 -400 µg ml -1 when required for selection. [25, 64] . Stable transformants were obtained after a sequence of passages on selective and non-selective media. After transformation of plasmids with the hph selection marker, hygromycin B-resistant colonies were selected on YEPD agar plates supplemented with 150 -400 mg l -1 hygromycin B (200 mg l -1 for A.adeninivorans LS3 and 135, 250 mg l -1 for D.hansenii H158 and D.polymorphus H120, 400 mg l -1 for H. polymorpha MedHp1, 150 mg l -1 for P. pastoris GS115and S. cerevisiae C13ABYS86). Single colonies were isolated and grown on YEPD medium and hygromycin B at 30°C for 2 days. This step was repeated three times before the cells were plated on non-selective YEPD agar and grown for 3-5 days at 30°C. A single colony from each transformant was isolated and defined as a strain.
Yeast transformation
In case of auxothrophy complementation the transformants were selected on YMM agar plates lacking the respective amino acid.
Isolation and characterisation of nucleic acids
Plasmid DNA, restriction fragment isolation, labeling of fragments and Southern transfer were carried out as previously described by [32, 65] .
Protein analysis SDS-PAGE with 6 µg cell extract protein and Western blots were performed as described by [66] . The dye binding method of Bradford [67] was used for quantitative determination of protein concentration in cell extract with bovine serum albumin as a standard protein. IL-6 and IFNγ were immunologically detected by Western blot analysis using specific anti-IL-6 or IFNγ antibodies (R&D systems/USA) for detection. Blots were stained with Western Blue Stabilized Substrate (Promega, Germany).
IFNγ samples were digested with PNGaseF (Boehringer, Mannheim) following the instructions of the supplier. Untreated and digested samples were separated and visualized as described before.
Fluorescence microscopy GFP expression was visualized in yeast cells by fluorescence microscopy (Axioskop, Zeiss Jena, Germany; excitation at 470 nm and detection using the BP500-530 nm emission filter). These conditions allowed visualization of GFP-mediated fluorescence avoiding a significant autofluorescence background. Single images (512 × 512 pixels) were collected using line-averaging eight times, each for 1 s.
Measurement of yeast dry mass and PHA
PHA, detected using gas chromatography/mass spectrometry, and yeast dry mass were measured as described by [68, 69] .
Estrogenic activity assay
A. adeninivorans G1211 transformed with the plasmids pAL-HPH-hERα and pAL-ALEU2m-GAA(xERE)-phyK (G1211/pAL-HPH-hERα -pAL-ALEU2m-GAA(xERE)-phyK) was the bio component of the assay. These cells were cultured in YMM with 2% glucose at 30°C for 48 h and stored as 50 µl aliquots. For detection of estrogenic activity, 950 µl of the samples were supplemented with 2% maltose (final concentration) and 50 µl of stationary yeast cell suspension (final OD 600 nm = 1) was added. The suspension was cultured for 30 h at 30°C on a shaker.
Subsequently all samples were centrifuged for 10 min at 5000 × g to separate the cells from the cultivation medium. The extracellularly accumulated phytase activity was assessed through a modified method initially described by [70, 71] . Aliquots (25 µl) of the supernatant samples were incubated with 25 µl 0.1 M sodium-citrate (pH 3.9) containing 3.5 mM 4-nitrophenyl phosphate for 60 min at 37°C in microtitre plates. The reaction was stopped by adding 50 µl 15% TCA. After adding of 100 µl 1 N sodium hydroxide, 4-nitrophenol was measured at 405 nm with the reader "Sunrise" from Tecan (USA) [45] .
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